MedTrace Logo

Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children

NCT04415983 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-06-04

No results posted yet for this study

Summary

Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children

Conditions

  • Helicobacter Pylori Infection

Interventions

DRUG

Nitazoxanide

Nitazoxanide twice daily

DRUG

Clarithromycin

Klacid twice daily

DRUG

Metronidazole

Metronidazole twice daily

DRUG

Proton pump inhibitor

Omeprazoe twice daily

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Rasha Gamal, Ass. Prof. · Pediatrics department - Tanta University

  • sherief Abd-Elsalam, ass. Prof. · Tanta University Faculty of medicine

  • Abeer Salamah, Lecturer · Pediatrics department - Kafr Elsheikh University

  • dina shawky, lecturer · Pediatrics department - Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2030-10-01
Completion
2030-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04415983 on ClinicalTrials.gov